KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 259 filers reported holding KARUNA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.43 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $26,693,224 | +7.3% | 157,864 | +15.2% | 0.01% | 0.0% |
| Q2 2023 | $24,880,685 | 0.0% | 136,978 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $24,880,685 | +16.4% | 136,978 | +25.9% | 0.01% | +9.1% |
| Q4 2022 | $21,381,560 | -99.9% | 108,812 | +3.1% | 0.01% | -15.4% |
| Q3 2022 | $23,742,035,000 | +13.9% | 105,553 | -35.9% | 0.01% | +18.2% |
| Q2 2022 | $20,837,336,000 | -32.4% | 164,709 | -32.3% | 0.01% | -15.4% |
| Q1 2022 | $30,838,626,000 | -2.1% | 243,226 | +1.2% | 0.01% | +8.3% |
| Q4 2021 | $31,498,033,000 | +18.9% | 240,443 | +11.0% | 0.01% | +9.1% |
| Q3 2021 | $26,492,153,000 | +1.1% | 216,563 | -5.8% | 0.01% | 0.0% |
| Q2 2021 | $26,203,679,000 | -5.4% | 229,877 | -0.2% | 0.01% | -8.3% |
| Q1 2021 | $27,702,796,000 | +9.8% | 230,415 | -7.2% | 0.01% | 0.0% |
| Q4 2020 | $25,237,496,000 | +45.2% | 248,425 | +10.5% | 0.01% | +33.3% |
| Q3 2020 | $17,378,984,000 | -30.7% | 224,767 | -0.1% | 0.01% | -40.0% |
| Q2 2020 | $25,078,612,000 | +118.5% | 225,001 | +41.1% | 0.02% | +87.5% |
| Q1 2020 | $11,478,456,000 | – | 159,423 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 2,912,872 | $369,323,000 | 52.78% |
| Pivotal bioVenture Partners Investment Advisor LLC | 852,708 | $108,115,000 | 51.15% |
| Sofinnova Investments, Inc. | 1,953,077 | $247,631,000 | 18.79% |
| Nan Fung Group Holdings Ltd | 234,811 | $29,772,000 | 14.12% |
| Sands Capital Ventures, LLC | 267,895 | $33,966,000 | 7.10% |
| Logos Global Management LP | 340,000 | $43,109,000 | 5.59% |
| DAFNA Capital Management LLC | 82,053 | $10,403,000 | 2.71% |
| Ghost Tree Capital, LLC | 60,000 | $7,607,000 | 1.65% |
| CATALYST PRIVATE WEALTH, LLC | 24,976 | $3,167,000 | 1.58% |
| Eventide Asset Management | 748,000 | $94,839,000 | 1.49% |